Creator of DuraFuse™ Spinal Dural Clip
NeuraMedica is a medical device company located in Oregon City, Oregon, focused on the commercialization of DuraFuse, a novel, bioabsorbable, surgical clip for spinal dura closure.
The company was founded in 2014, based on an idea by Neil Roundy, MD, developed out of Oregon Health and Science University (OHSU). Biomedical engineer Rachel Dreilinger developed early prototypes with grants from the OHSU Oregon Clinical and Translational Research Institute (OCTRI). Together they founded NeuraMedica to commercialize the Dural Clip and Applier system.
NeuraMedica holds multiple patents on its proprietary technology and has several pending patents.
Meet Our Executives & Board
Meet Our Team
NeuraMedica is proud to have raised more than $3.5 million in funding and grants since 2014.
2013Dural Clip Idea ConceivedNeil Roundy, MD is awarded seed-level funding from the Oregon Health & Sciences University (OHSU) Oregon Clinical and Translational Research Institute (OCTRI) for a dural clip concept and brings in Rachel Dreilinger as a consultant to develop early-stage prototypes. They develop nine prototypes, file two patent applications, and are awarded a total of $67,000 in grants from OHSU.
2014NeuraMedica FoundedMs. Dreilinger and Dr. Roundy decide to partner, co-found NeuraMedica, and continue development of their dural clip prototypes with the intent of creating a game-changing technology for closure of the dura mater.
2015Technology LicenseNeuraMedica negotiates an exclusive license from OHSU for their dural clip technology. Oregon Nanoscience and Microtechnologies Institute (ONAMI) invests $250,000. Together, Ms. Dreilinger and Dr. Roundy continue development of their dural clip and applier.
2016ONAMI GrantNeuraMedica is awarded a $45,000 Internship Program Grant from ONAMI, allowing the company to hire a PhD to assist with grant-writing. NeuraMedica applies for a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I Grant.
2017NSF GrantNeuraMedica is awarded a $225,000 NSF SBIR Phase I Grant, finalizes its dural clip design, and begins testing.
2018NIH GrantNeuraMedical is awarded a $1,500,000 National Institutes of Health (NIH) grant, $50,000 SBIR Phase 1 Matching Grant from Business Oregon, and raises a $100,000 friends-and-family round of investment to continue development of its dural clip.
2019Business Oregon GrantNeuraMedica is awarded an SBIR Phase II Matching Grant from Business Oregon in the amount of $150,000.
2020Animal Study CompletedNeuraMedica is awarded a $100,000 SBIR Phase II Matching Grant from Business Oregon, and completes its Pivotal Large Animal Study.
2021FDA 510(k) ApplicationNeuraMedica raises a $1,000,000 investment from Michael Tippie of Alignment Ventures, is awarded a $50,000 Enhanced Innovation Grant from Business Oregon, completes its Surgeon Usability Study, registers the DuraFuse Trademark, and submits its FDA 510(k) application in December.
2022FDA ClearanceNeuraMedica receives FDA clearance for its DuraFuse Dural Clip.